Holen Sie sich die Stockscreener-App
8.395
1.88%
0.155
Handel nachbörslich:
8.30
-0.095
-1.13%
Finanzdaten der Ars Pharmaceuticals Inc-Aktie (SPRY)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
13.58%
28.09
|
32.50 | 7.973 | 86.58 | 2.068 |
Operating Expenses
|
18.84%
69.55
|
85.69 | 45.15 | 39.38 | 23.82 |
| Benefits Costs and Expenses |
255.66
|
- | - | 80.86 | - |
| Costs And Expenses |
28.25%
61.48
|
85.69 | 45.15 | 28.02 | 23.82 |
| Depreciation and Amortization |
0.417
|
- | 0.28 | - | 0.10 |
| Operating Income/Loss |
22.05%
-41.47
|
-53.19 | -37.18 | 47.20 | -21.75 |
| Income/Loss From Continuing Operations Before Tax |
800.19%
-227.57
|
32.50 | 7.973 | 5.718 | 2.068 |
| Income/Loss From Continuing Operations After Tax |
19.21%
-41.32
|
-51.15 | -33.94 | 49.93 | -19.13 |
|
Net Income/Loss
|
19.21%
-41.32
|
-51.15 | -33.94 | 49.93 | -19.13 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.84%
0.1537
|
98.81 | 98.06 | 0.1538 | 97.03 |
| Diluted Average Shares |
99.84%
0.1537
|
98.81 | 98.06 | 5.608 | 97.03 |
| Basic Earnings Per Share |
19.23%
-0.42
|
-0.52 | -0.35 | 0.51 | -0.20 |
| Diluted Earnings Per Share |
19.23%
-0.42
|
-0.52 | -0.35 | 0.51 | -0.20 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.18%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):